Just Asking for Money Is Not a Strategy
Somewhere between the lab bench and the pitch deck, a strange thing happens to many biotech founders. These are individuals
The Great European Biopharma Bottleneck: Capital Starved and Talent Stifled
European biopharma is a maddening paradox. It has the academic firepower to generate groundbreaking discoveries but lacks the financial machinery
First Principles: How to Think Like a Greek and Build Like a Founder
There’s an old saying in Silicon Valley: when in doubt, invoke physics. And so the term “first principles” has
Get Messy: Why Diving In Beats Waiting for Perfection
There’s a curious delusion that haunts modern professionals. The belief that before you start something—anything, really—you must
P-Hacking: The Fine Art of Massaging Numbers into Compliance
What Is a p-Value?
The p-value measures the probability of observing data as extreme as the actual results, assuming the
The Runway Is Shorter Than It Looks
There’s a specific look founders get when I ask, “What’s your runway?” It’s part shame, part bravado,
The Cocktail Party Problem: How to Survive Conferences, Science, and Other Noisy Mistakes
There you are—armed with a lukewarm flute of prosecco, trying to make small talk with a stem cell biologist
Let’s Do It: A Short Manifesto for the Overcommitted
There’s a peculiar optimism embedded in the English language: pulling yourself up by your bootstraps. The phrase is now
In Praise of Productive Delusion
In Germany, there is a saying: "Wenn du Visionen hast, geh zum Arzt.” If you have visions, see a
Simping for Capital: The Cult of the Curated Investor List
In the courtship rituals of modern fundraising, there exists a peculiar form of digital simping: the obsessive fawning over “curated
